146 results on '"Shanehsazzadeh, Saeed"'
Search Results
2. Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin
3. Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection
4. Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin
5. Graphene/cobalt nanocarrier for hyperthermia therapy and MRI diagnosis
6. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer
7. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles
8. Nano Delivery Systems
9. Estimated human absorbed dose of 177Lu–BPAMD based on mice data: Comparison with 177Lu–EDTMP
10. Quantitative Effect of Magnetic Field Strength on PEGylated Superparamagnetic Iron Oxide Nanoparticles
11. PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study
12. Biodistribution evaluation of 166Ho–DTPA–SPION in normal rats
13. Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with 177Lu-EDTMP
14. Comparison of estimated human dose of 68Ga-MAA with 99mTc-MAA based on rat data
15. Comparison of estimated human effective dose of 67Ga- and 99mTc-labeled bombesin based on distribution data in mice
16. Estimated human absorbed dose for 68Ga-ECC based on mice data: comparison with 67Ga-ECC
17. Effect of Functional Group and Surface Charge of PEG and Dextran-Coated USPIO as a Contrast Agent in MRI on Relaxivity Constant
18. Assessment of human effective absorbed dose of 67 Ga–ECC based on biodistribution rat data
19. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence
20. Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine in humans on the basis of biodistribution data of rats
21. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice
22. Prognostic value of radiomics parameters of PET/CT in patients with oropharyngeal carcinoma: A systematic review and meta- analysis
23. Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers
24. Estimation of human effective absorbed dose of 67Ga–cDTPA–gonadorelin based on biodistribution rat data
25. Preclinical Evaluation of 68Ga-MAA from Commercial Available 99mTc-MAA Kit
26. Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI
27. Preliminary studies of 68Ga-NODA-USPION-BBN as a dual-modality contrast agent for use in positron emission tomography/magnetic resonance imaging
28. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents
29. Preliminary studies of 68Ga-NODA-USPION-BBN as a dual-modality contrast agent for use in positron emission tomography/magnetic resonance imaging.
30. Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling
31. Dual nano-sized contrast agents in PET/MRI: a systematic review
32. How Size and Composition of Cobalt Doped Iron Oxide Nanoparticle Tracers Enhance Magnetic Particle Imaging Performance
33. PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study
34. Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process
35. Preclinical dosimetric estimation of [111In] 5, 10, 15, 20-tetra phenyl porphyrin complex as a possible imaging/PDT agent
36. Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT/MRI imaging agent
37. Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain
38. Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with 177Lu-EDTMP
39. Biodistribution evaluation of 166Ho–DTPA–SPION in normal rats
40. PEGylated superparamagnetic iron oxide nanoparticles labeled with Ga as a PET/MRI contrast agent: a biodistribution study.
41. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cellsin vitrobut notin vivo
42. Assessment of human effective absorbed dose of 67 Ga–ECC based on biodistribution rat data
43. Biodistribution of 80nm iron oxide nanoparticles labeled with 99mTc in Balb/c mice
44. Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation
45. Modified Gadonanotubes as a promising novel MRI contrasting agent
46. Effect of Coating Materials on Lymph Nodes Detection Using Magnetite Nanoparticles
47. Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling
48. Preclinical dosimetric estimation of [111In] 5, 10, 15, 20-tetra phenyl porphyrin complex as a possible imaging/PDT agent.
49. Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT/MRI imaging agent.
50. Preparation and biological assessment of Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with Lu-EDTMP.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.